Skip to main content
Log in

Fokus Nephrologie

Intensivmedizinische Studien aus 2019/2020

Focus nephrology

Intensive medical care studies from 2019/2020

  • Journal Club
  • Published:
Der Anaesthesist Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1

Literatur

  1. Kellum JA, Prowle JR (2018) Paradigms of acute kidney injury in the intensive care setting. Nat Rev Nephrol 14(4):217–230

    Article  Google Scholar 

  2. Rosner MH, Perazella MA (2017) Acute kidney injury in patients with cancer. N Engl J Med 377(5):500–501

    PubMed  Google Scholar 

  3. Hoste EA et al (2015) Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 41(8):1411–1423

    Article  Google Scholar 

  4. Koyner JL et al (2020) The impact of biomarkers of acute kidney injury on individual patient care. Nephrol Dial Transplant 35(8):1295–1305

    Article  Google Scholar 

  5. Nusshag C et al (2017) Issues of acute kidney injury staging and management in sepsis and critical illness: a narrative review. Int J Mol Sci 18(7):1387

    Article  Google Scholar 

  6. Thomas ME et al (2015) The definition of acute kidney injury and its use in practice. Kidney Int 87(1):62–73

    Article  Google Scholar 

  7. Saha M, McDaniel JK, Zheng XL (2017) Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics. J Thromb Haemost 15(10):1889–1900

    Article  CAS  Google Scholar 

  8. Nusshag C et al (2019) Cell cycle biomarkers and soluble urokinase-type plasminogen activator receptor for the prediction of sepsis-induced acute kidney injury requiring renal replacement therapy: a prospective, exploratory study. Crit Care Med 47(12):e999–e1007

    Article  CAS  Google Scholar 

  9. Wei C et al (2011) Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 17(8):952–960

    Article  CAS  Google Scholar 

  10. Backes Y et al (2012) Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review. Intensive Care Med 38(9):1418–1428

    Article  CAS  Google Scholar 

  11. Alfano M et al (2015) Full-length soluble urokinase plasminogen activator receptor down-modulates nephrin expression in podocytes. Sci Rep 5:13647

    Article  Google Scholar 

  12. Mondino A, Blasi F (2004) uPA and uPAR in fibrinolysis, immunity and pathology. Trends Immunol 25(8):450–455

    Article  CAS  Google Scholar 

  13. Dande RR et al (2017) Soluble urokinase receptor and the kidney response in diabetes mellitus. J Diabetes Res. https://doi.org/10.1155/2017/3232848

    Article  PubMed  PubMed Central  Google Scholar 

  14. Hayek SS et al (2015) Soluble urokinase receptor and chronic kidney disease. N Engl J Med 373(20):1916–1925

    Article  CAS  Google Scholar 

  15. Hayek SS et al (2020) Soluble urokinase receptor and acute kidney injury. N Engl J Med 382(5):416–426

    Article  CAS  Google Scholar 

  16. Chawla LS et al (2017) Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol 13(4):241–257

    Article  Google Scholar 

  17. Zewinger S et al (2018) Dickkopf‑3 (DKK3) in urine identifies patients with short-term risk of eGFR loss. J Am Soc Nephrol 29(11):2722–2733

    Article  CAS  Google Scholar 

  18. Federico G et al (2016) Tubular Dickkopf‑3 promotes the development of renal atrophy and fibrosis. JCI Insight 1(1):e84916

    Article  Google Scholar 

  19. Schunk SJ et al (2019) Association between urinary dickkopf‑3, acute kidney injury, and subsequent loss of kidney function in patients undergoing cardiac surgery: an observational cohort study. Lancet 394(10197):488–496

    Article  CAS  Google Scholar 

  20. Zarbock A et al (2016) Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial. JAMA 315(20):2190–2199

    Article  CAS  Google Scholar 

  21. Gaudry S et al (2016) Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med 375(2):122–133

    Article  Google Scholar 

  22. Barbar SD et al (2018) Timing of renal-replacement therapy in patients with acute kidney injury and sepsis. N Engl J Med 379(15):1431–1442

    Article  CAS  Google Scholar 

  23. Klein SJ et al (2018) Biomarkers for prediction of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis. Intensive Care Med 44(3):323–336

    Article  CAS  Google Scholar 

  24. Hoste E et al (2020) Identification and validation of biomarkers of persistent acute kidney injury: the RUBY study. Intensive Care Med 46(5):943–953

    Article  CAS  Google Scholar 

  25. Ronco C (2019) Acute kidney injury biomarkers: Are we ready for the biomarker curve? Cardiorenal Med 9(6):354–357

    Article  Google Scholar 

  26. Jin K et al (2017) Intensive monitoring of urine output is associated with increased detection of acute kidney injury and improved outcomes. Chest 152(5):972–979

    Article  Google Scholar 

  27. Kellum JA et al (2015) Classifying AKI by urine output versus serum creatinine level. J Am Soc Nephrol 26(9):2231–2238

    Article  CAS  Google Scholar 

  28. Garnier F et al (2020) Reversibility of acute kidney injury in medical ICU patients: predictability performance of urinary tissue inhibitor of metalloproteinase‑2 x insulin-like growth factor-binding protein 7 and renal resistive index. Crit Care Med 48(4):e277–e284

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. A. Weigand.

Ethics declarations

Interessenkonflikt

C. Nusshag, C.J. Reuß, M. Dietrich, A. Hecker, C. Jungk, D. Michalski, M.O. Fiedler, M. Bernhard, C. Beynon, M. A. Weigand und T. Brenner geben an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nusshag, C., Reuß, C.J., Dietrich, M. et al. Fokus Nephrologie. Anaesthesist 70, 250–256 (2021). https://doi.org/10.1007/s00101-020-00856-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00101-020-00856-w

Navigation